Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-29 Sale | 2023-01-03 6:36 pm | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 54,042 | $6.0058 | $324,564 | 1,493,032 (Direct) | View |
| 2022-10-04 Sale | 2022-10-06 4:20 pm | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 2,109 | $6.2562 | $13,194 | 991,005 (Direct) | View |
| 2022-09-29 Sale | 2022-10-03 6:26 pm | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 141,041 | $6.0466 | $852,825 | 1,603,063 (Direct) | View |
| 2022-09-16 Sale | 2022-09-20 4:59 pm | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 22,592 | $6.02 | $136,004 | 484,321 (Direct) | View |
| 2022-06-17 Sale | 2022-06-17 4:57 pm | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 60,000 | $6.2084 | $372,505 | 497,397 (Direct) | View |
| 2022-06-14 Sale | 2022-06-16 4:19 pm | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 10,000 | $5.5 | $55,000 | 497,397 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-26 Equity Swap | 2023-06-26 4:05 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 17,547 | $9.1 | 0 (Direct) | View |
| 2023-06-26 Disposition | 2023-06-26 4:05 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 1,663,612 | $0 | 0 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-16 5:52 pm | N/A 2033-03-14 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-12-30 Option Award | 2023-01-03 6:36 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 214 | $5.1085 | 1,493,032 (Direct) | View |
| 2022-12-29 Exercise | 2023-01-03 6:36 pm | N/A 2029-02-19 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 54,042 | $0 | 1,493,032 (Direct) | View |
| 2022-12-29 Exercise | 2023-01-03 6:36 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 54,042 | $0.9489 | 1,493,032 (Direct) | View |
| 2022-10-04 Exercise | 2022-10-06 4:20 pm | N/A 2029-02-19 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 2,109 | $0 | 991,005 (Direct) | View |
| 2022-10-04 Exercise | 2022-10-06 4:20 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 2,109 | $0.9489 | 991,005 (Direct) | View |
| 2022-09-29 Exercise | 2022-10-03 6:26 pm | N/A 2029-02-19 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 141,041 | $0 | 1,603,063 (Direct) | View |
| 2022-09-29 Exercise | 2022-10-03 6:26 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 141,041 | $0.9489 | 1,603,063 (Direct) | View |
| 2022-06-30 Option Award | 2022-09-20 4:59 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 9,516 | $2.1165 | 484,321 (Direct) | View |
| 2022-09-16 Exercise | 2022-09-20 4:59 pm | N/A 2029-02-19 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 22,592 | $0 | 484,321 (Direct) | View |
| 2022-09-16 Exercise | 2022-09-20 4:59 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 22,592 | $0.9489 | 484,321 (Direct) | View |
| 2022-06-17 Exercise | 2022-06-17 4:57 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 50,000 | $3.3 | 497,397 (Direct) | View |
| 2022-06-17 Exercise | 2022-06-17 4:57 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 10,000 | $1 | 497,397 (Direct) | View |
| 2022-06-17 Exercise | 2022-06-17 4:57 pm | N/A 2030-03-11 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 60,000 | $0 | 497,397 (Direct) | View |
| 2022-06-14 Exercise | 2022-06-16 4:19 pm | N/A 2029-02-19 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 10,000 | $0 | 497,397 (Direct) | View |
| 2022-06-14 Exercise | 2022-06-16 4:19 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 10,000 | $0.9489 | 497,397 (Direct) | View |
| 2021-06-30 Option Award | 2022-03-11 7:41 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 1,782 | $2.125 | 287,397 (Direct) | View |
| 2021-12-31 Option Award | 2022-03-11 7:41 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 1,817 | $2.108 | 287,397 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 7:41 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 280,000 | $0 | 287,397 (Direct) | View |
| 2020-07-01 Option Award | 2021-03-12 6:41 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 3,798 | $0.98 | 203,798 (Direct) | View |
| 2020-03-11 Option Award | 2020-03-13 7:51 pm | N/A 2030-03-11 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 350,000 | $0 | 350,000 (Direct) | View |